Nutrien remains a Hold, with current valuation above intrinsic value and insufficient margin of safety amid macro uncertainty. Q1 saw record potash sales and strong revenue growth, but higher input ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results